The authors recently published data from a prospective cohort study of postmenopausal women (N Engl JMecM992;326:1323-9) which suggested that a high waist/hip ratio was associated with a significantly increased risk of breast cancer in women with a positive family history of breast cancer. Since families with aggregations of breast and ovarian cancer demonstrate more consistent genetic linkage to markers on chromosome 17q than do families with breast cancer alone, the authors performed additional analyses to examine whether the previously observed associations with waist/hip ratio differed when family history of breast cancer was partitioned according to whether or not ovanan cancer was also present in a close relative. Between 1986 and 1990,620 incident cases of breast cancer were identified in a cohort of 37,105 postmenopausal Iowa women A family history of breast cancer in first-degree relatives was associated with a relative nsk of 1.34 (95% confidence interval (Cl) 1.07-1 69), a family history of both breast and ovarian cancer was associated with a relative nsk of 2.36 (95% Cl 1.12-4.98). Consistent with the authors' findings after 4 years of follow-up, a high waist/hip ratio (>80th percentile vs. <80th percentile) was associated with increased nsk of breast cancer in the presence of a family history of breast cancer (relative nsk (RR) = 2.10, 95% Cl 1.43-3.09) but not in the absence of a family history of breast cancer (RR = 1.12). The combination of a high waist/hip ratio with a family history of breast and ovanan cancer was associated with 4.83-fold increased risk (95% Cl 1.55-15.1). Neither a family history of breast cancer nor a family history of ovanan cancer was associated with significantly increased nsk in the absence of a high waist/hip ratio. Am J Epidemiol 1993; 138:799-803. anthropometry; breast neoplasms, obesity; ovanan neoplasms, prospective studies While familial aggregation of breast cancer has long been recognized (1-3), only re-
cently has convincing evidence been provided that at least a portion of familial cases of the disease are associated with inherited susceptibility (4) . A specific chromosomal region (17q) demonstrates genetic linkage not only in familial breast cancer but also in families with aggregations of both breast and ovarian cancer (5) . A breast cancer consortium has been formed (6) to enhance efforts to identify and sequence the relevant gene, now known as BRCA1 (7) . An intriguing result is that close to 100 percent of the families with occurrences of both breast and ovarian cancer demonstrate genetic linkage to markers on chromosome 17q (8) . Conversely, this linkage is demonstrable in less than 50 percent of the families with a high occurrence of breast cancer alone.
Breast cancer is likely to be heterogeneous (9, 10) . It has been proposed that one method of defining homogeneous subsets is to partition families according to interfamilial differences in distributions of epidemiologic risk factors (11) (12) (13) . Using this line of reasoning, we recently described an interaction between family history of breast cancer and body fat distribution in the risk of postmenopausal breast cancer (14) : Abdominal adiposity was associated with a nonsignificant 20 percent elevated risk among women without a family history of breast cancer but a 2.4-fold elevated risk among women with a positive family history. Given the discrepant reports of linkage for breast cancer families versus breastovarian cancer families, we performed additional analyses to consider separately interactions of a high waist/hip ratio with family history of breast cancer and family history of breast-ovarian cancer.
MATERIALS AND METHODS

The Iowa Women's Health Study cohort
Details of the study design were reported previously (15) . Briefly, participants were a sample of 41,837 women between the ages of 55 and 69 years in 1985. The cohort of women considered to be at risk for incident breast cancer excluded those who reported on the baseline questionnaire that they were premenopausal (n = 569) or that they had had a previous total (n = 1,764) or partial (n = 106) mastectomy. The additional exclusion of 2,293 women with a history of cancer at baseline left 37,105 women at risk.
Data collection
The baseline survey included questions on sociodemographic variables, gynecologic history, cancer, and other medical conditions or diseases. Participants reported their current height and weight, and a paper tape measure and written instructions were enclosed so that a friend of the participant could measure the circumference of her waist and hips. The measurements obtained by this protocol are both accurate and reliable (16) . Body mass index (weight (kg)/ height (m) 2 ) and the ratio of waist circumference to hip circumference (waist/hip ratio) were computed.
Data were collected on the family's history of cancer for mothers, grandmothers, aunts, sisters, and daughters. Specific categories included cancer of the breast, ovary, uterus or endometrium, cervix, and a reproductive organ of unknown site. No questions were asked on family size or age at onset, nor was any attempt made to validate the occurrence of cancer in family members.
Five-year follow-up for cancer occurrence in the cohort was accomplished using the State Health Registry of Iowa.
Data analysis
Family history of cancer was classified according to the cancer sites reported among first-degree family members. A family history of breast cancer only was assigned if at least one relative had had breast cancer but no first-degree relatives had had ovarian cancer. A family history of ovarian cancer only was assigned if at least one relative had had ovarian cancer but no relatives had had breast cancer. The third family history category was defined as at least one relative who had had breast cancer and one relative who had had ovarian cancer. Women who reported no first-degree relatives with breast or ovarian cancer were considered to have a negative family history.
Cutpoints for quintiles of waist/hip ratio were determined from the total cohort at risk. Because of small numbers in some categories, the quintiles were collapsed into two categories: the upper quintile (^0.906) versus the lower four (<0.906).
Age-adjusted relative risks and corresponding 95 percent confidence intervals were calculated using the Mantel-Haenszel procedure (17) for four age groups: 55-59, 60-64,65-69, and 70-74 years. We ran tests for linear trend based on Mantel's extension to examine dose response (18) . Multiplicative interactions were evaluated within the context of proportional hazards regression (19) by comparison of the -2 log likelihoods of models with and without cross-product terms.
RESULTS
A total of 1,290 women (3.5 percent) could not be classified according to their family history of cancer because of missing information. Among the remainder, 11.4 percent reported a family history of breast cancer only, 1.4 percent reported a family history of ovarian cancer only, and 0.5 percent reported a family history of both breast and ovarian cancer.
During 5 years of follow-up, 620 cases of breast cancer occurred-87 cases among women with a family history of breast cancer only (relative risk (RR) = 1.34, 95 percent confidence interval (CI) 1.07-1.69) and 7 among women with a family history of both breast and ovarian cancer (RR = 2.36, 95 percent CI 1.12-4.98). No excess risk of breast cancer was evident among women with a family history of ovarian cancer alone (RR = 0.90). Table 1 shows results of analyses carried out to examine the effects of interactions between family history of cancer and waist/hip ratio on breast cancer risk. Consistent with our findings after 4 years of follow-up (14), a high waist/hip ratio was not associated with a significantly increased risk of breast cancer in the absence of a family history of breast cancer. The combination of a high waist/hip ratio and a family history of breast cancer was associated with a 2.1-fold increased risk of breast cancer. When the family history included breast cancer and ovarian cancer, the relative risk was more pronounced (RR = 4.8) but not statistically different. Neither a family history of breast cancer nor a family history of breast-ovarian cancer was associated with significantly increased risk of breast cancer in women without a high waist/hip ratio. None of the observed interactions involving family history and waist/hip ratio were altered when they were adjusted for age at first live birth, number of live births, age at menarche, age at menopause, oral contraceptive use, education, and body mass index using Cox proportional hazards regression.
A number of studies have shown that obesity (20) (21) (22) and body fat distribution (22) (23) (24) are influenced by genetic factors. If the familial aggregation of breast and ovarian cancer in postmenopausal women and familial patterns of abdominal adiposity were part of a common mechanistic pathway, one would expect to observe a higher frequency of a positive family history of cancer among women with a high waist/hip ratio; no such association was observed (25) . The prevalence of a family history of breast cancer among women with a waist/hip ratio in the lowest 80 percent of the distribution was 11.3 percent, and such a history was present in only 11.8 percent of women with a waist/ hip ratio in the upper quintile. The prevalence of a family history of breast-ovarian cancer was 0.5 percent and 0.6 percent in these two groups, respectively.
DISCUSSION
A high waist/hip ratio was associated with a significantly increased risk of breast cancer in this cohort only in women with a positive family history of breast cancer (14) . Because of the heterogeneity of linkage associated with familial breast cancer versus breast-ovarian cancer, we performed additional analyses in which family history of breast cancer was partitioned according to whether or not ovarian cancer was also present in a close relative. We found a somewhat higher risk of postmenopausal breast cancer among women with a high waist/hip ratio who had a familial history of breastovarian cancer than among such women with familial breast cancer alone (RR = 4.8 vs. 2.1), independent of other breast cancer risk factors. Although, at the present time, these two risk estimates are not statistically significantly different from each other, continued follow-up of this cohort will permit determination of whether or not the observed differences represent true heterogeneity of association.
The linkage studies that provided evidence of a breast cancer susceptibility gene (BRCA1) on chromosome 17q focused primarily on families with premenopausal breast or ovarian cancer (4, 5, 7). Thus, while it is reasonable to question the relevance of the present findings regarding postmenopausal breast cancer to the BRCA1 gene, several pieces of evidence suggest that consideration is appropriate. First, Margaritte et al. (26) reanalyzed the series of 23 families of Hall et al. (4) that included both pre-and postmenopausal cases and showed that, after allowing for the higher probability of sporadic versus inherited disease at older ages (27) , linkage heterogeneity based on age at onset was no longer significant. Second, although all of the incident cases of breast cancer in this cohort were postmenopausal, some of the women with a positive family history may be members of families with premenopausal disease. Third, the highest relative risk noted in the present study involved a high waist/hip ratio and a family history of breast-ovarian cancer, the latter a combination of malignancies for which linkage homogeneity has thus far been observed. Investigators with panels of breast or breast-ovarian cancer families should consider using waist/hip ratio as a characteristic to partition families into more homogeneous subsets.
